Eritoran, a complex molecule with two hexose rings and two phosphate groups, blocks the inflammation pathway mediated by Toll-like receptor (TLR) 4. This mechanism is present in sepsis, but late-stage clinical trials on eritoran failed to show activity against that condition.
Recently, S. N. Vogel and colleagues at the University of Maryland, Baltimore, showed that eritoran combats flu in rodents. Instead of attacking the flu virus, it treats TLR 4–related inflammation and prevents lung damage.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.